Research
Dr. Pallanti's most recent interested is Clinical Transcranial Magnetic Stimulation (rTMS / deep TMS ) in adult and young adult with Resistant disorders,Depression Bipolar nd Psychotic disorders including Schizophrenia spectrum, Prodromal, early Onset, treatment of Resistant Hallucination, treatment of Negative and Cognitive Symptoms in Schizophrenia and treatment of Resistant OCD-Impulsive Spectrum Disorder, including Autism Spectrum Disorder. Anxiety, OCD spectrum disorders including Pathological Gambling and other Behavioral Addiction and Impulse Control.
Dr. Pallanti's role within the Department of Psychiatry has included organizing and directing Mount Sinai's Center of Excellence for OCD, impulsive, and behavioral addiction. Under his leadership as Director, the Center broke into new ground with its cutting-edge approaches to treatment and an innovative blend of therapeutic programs, research and educational activities.
Google scholar: http://scholar.google.com/citations?user=OTodZXQAAAAJ&hl=en
Dr. Pallanti's role within the Department of Psychiatry has included organizing and directing Mount Sinai's Center of Excellence for OCD, impulsive, and behavioral addiction. Under his leadership as Director, the Center broke into new ground with its cutting-edge approaches to treatment and an innovative blend of therapeutic programs, research and educational activities.
Google scholar: http://scholar.google.com/citations?user=OTodZXQAAAAJ&hl=en
Education
MD, Florence University
Florence School of Medicine
Florence School of Medicine
Office Locations
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Pallanti has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Pallanti has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.